Quality of life in individuals with attenuated psychotic symptoms: Possible role of anxiety, depressive symptoms, and socio-cognitive impairments

Individuals with Clinical High-Risk state for Psychosis (CHR-P) are reported to exhibit impaired quality of life (QOL) similar to that observed in schizophrenia, but its determinants remain unclear. We investigated the QOL of 33 subjects with CHR-P, 45 patients with schizophrenia, and 63 healthy sub...

Full description

Saved in:
Bibliographic Details
Published inPsychiatry research Vol. 257; pp. 431 - 437
Main Authors Takahashi, Tsutomu, Higuchi, Yuko, Komori, Yuko, Nishiyama, Shimako, Nakamura, Mihoko, Sasabayashi, Daiki, Nishikawa, Yumiko, Sumiyoshi, Tomiki, Suzuki, Michio
Format Journal Article
LanguageEnglish
Published Ireland Elsevier B.V 01.11.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Individuals with Clinical High-Risk state for Psychosis (CHR-P) are reported to exhibit impaired quality of life (QOL) similar to that observed in schizophrenia, but its determinants remain unclear. We investigated the QOL of 33 subjects with CHR-P, 45 patients with schizophrenia, and 63 healthy subjects using the Quality of Life Scale (QLS). The CHR-P and schizophrenia groups were administered the Brief Assessment of Cognition in Schizophrenia (BACS), the Schizophrenia Cognition Rating Scale (SCoRS), and the Social and Occupational Functioning Assessment Scale (SOFAS) for socio-cognitive functions; and the Positive and Negative Syndrome Scale (PANSS) and the State-Trait Anxiety Inventory for clinical symptoms. The CHR-P group was also assessed using the Beck Depression Inventory. The CHR-P and schizophrenia groups had a significantly lower QLS score to the same degree compared with controls, which was predominantly associated with the SOFAS, SCoRS, and PANSS negative/general scores. For the CHR-P, the severity of anxiety and depressive symptoms was also correlated with a lower QLS score. Regression analyses demonstrated that the QLS score was predicted by SOFAS (for both groups) and SCoRS (for CHR-P) scores. Our findings suggest the importance of addressing socio-cognitive dysfunctions as well as anxiety and depressive symptoms for better QOL in CHR-P. •We examined QOL in high-risk for psychosis and schizophrenia groups.•Both groups exhibited impaired QOL to the same degree compared to controls.•Socio-cognitive deficits and negative symptoms were general determinants of QOL.•Anxiety/depressive symptoms were related to poor QOL in the high-risk group.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0165-1781
1872-7123
DOI:10.1016/j.psychres.2017.08.024